The conjugates were evaluated regarding their antiproliferative effect on prostate cancer cells (DU145 and PC-3) and the PDC GSG showed IC50 values similar to gemcitabine GSG that possessed the highest antiproliferative effect was utilized for further pharmacokinetic studies in mice. The gene discussed is PDC; the disease is prostate carcinoma.